2025-04-03T06:11:49Z

---

현대바이오사이언스(대표 진근우)가 한국노바티스, 한미약품 등 국내 및 글로벌 제약사에서 20년 이상 지낸 이지은 마케팅 전략 전문가를 해외개발 및 전략마케팅 상무로 영입했다. 이지은 신임 상무는 중앙대 화학과, 연세대 경영전문대학원(MBA)을 졸업한 후, 한미약품, 유유제약 등 국내 기업과, 한국노바티스, 한국먼디파마, 다케다제약 등 글로벌 제약사에서 항암제, 희귀질환, 신제품 론칭 등 다양한 경험과 실무를 담당해 온 마케팅 전략 전문가다. 이상무는 현대바이오의 해외 사업을 위한 원활한 환경을 조성하기 위해, 해외 사업개발 및 글로벌 마케팅 전략을 담당하게 되며, 항암플랫폼 기술 및 항바이러스 상업화 업무를 맡을 예정이다. 관련 기사 더 보기 Like this: Like Loading... Related Hyundai Bio, Lee Ji-eun appointed as Managing Director of Overseas Development and Strategic Marketing Hyundai Bioscience (CEO Jin Geun-woo) has hired Lee Ji-eun, a marketing strategy expert with over 20 years of experience at domestic and global pharmaceutical companies including Novartis Korea and Hanmi Pharmaceutical, as Managing Director of Overseas Development and Strategic Marketing. The new Managing Director, Lee Ji-eun, graduated from Chung-Ang University’s Department of Chemistry and Yonsei University’s Graduate School of Business (MBA). She is a marketing strategy expert with diverse experience and practical work in charge of anticancer drugs, rare diseases, and new product launches at domestic companies such as Hanmi Pharmaceutical and Yuhan Pharmaceutical, and global pharmaceutical companies such as Novartis Korea, Mundipharma Korea, and Takeda Pharmaceutical. To create a smooth environment for Hyundai Bio's overseas business, Lee Sang-moo will be in charge of overseas business development and global marketing strategies, and will be in charge of anticancer platform technology and antiviral commercialization. See more related articles Hyundai Bioscience and NIAID jointly develop avian influenza treatment Hyundai Bio, Lee Ji-eun nommé directeur général du développement à l'étranger et du marketing stratégique Hyundai Bioscience (PDG Jin Geun-woo) a embauché Lee Ji-eun, un expert en stratégie marketing avec plus de 20 ans d'expérience dans des sociétés pharmaceutiques nationales et internationales, notamment Novartis Korea et Hanmi Pharmaceutical, en tant que directeur général du développement à l'étranger et du marketing stratégique. Le nouveau directeur général, Lee Ji-eun, est diplômé du département de chimie de l'université Chung-Ang et de la Graduate School of Business (MBA) de l'université Yonsei. Elle est une experte en stratégie marketing avec une expérience diversifiée et un travail pratique en charge des médicaments anticancéreux, des maladies rares et des lancements de nouveaux produits dans des sociétés nationales telles que Hanmi Pharmaceutical et Yuhan Pharmaceutical, et des sociétés pharmaceutiques mondiales telles que Novartis Korea, Mundipharma Korea et Takeda Pharmaceutical. Afin de créer un environnement propice aux activités de Hyundai Bio à l'étranger, Lee Sang-moo sera en charge du développement commercial à l'étranger et des stratégies de marketing mondial, et sera en charge de la technologie de la plate-forme anticancéreuse et de la commercialisation des antiviraux. Voir plus d'articles connexes Hyundai Bioscience et le NIAID développent conjointement un traitement contre la grippe aviaire Like this: Like Loading...